A Study of ALXN1830 in Healthy Adult Participants
Study Identifier:
ALXN1830-HV-108
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Other
Study Details
Medical Condition
- Other
Study Drug
- Drug: ALXN1830
- Drug: Placebo
Date
Mar 2021 - Dec 2021
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 55 Years
Requirements Information
Sex
Female & Male
Age
18 - 55 Years
Study Details
Medical Condition
- Other
Study Drug
- Drug: ALXN1830
- Drug: Placebo
Date
Mar 2021 - Dec 2021
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 55 Years years
Requirements Information
Protocol Summary
This trial will study the effects of single and multiple doses of ALXN1830 in healthy adult participants.
Trial Locations
Location
Status
Location
Clinical Trial Site
Auckland, New Zealand
Status
N/A
Location
Research Site
Grafton, New Zealand, 1010
Status
N/A